Impact of Renin-Angiotensin-Aldosterone System Inhibition on Advanced Chronic Kidney Disease Progression: A Retrospective Observational Study
RAASi has no significant impact on the time to kidney failure in patients with advanced CKD. Hence, this study supports maintenance of RAASi in advanced CKD, if used for extrarenal indications such as cardiovascular protection.
Authors
- Thomas Welte (ORCID: https://orcid.org/0000-0003-4583-9216)
- Janis M. Nolde (ORCID: https://orcid.org/0000-0001-6864-8514)
- Georg Büchler
- Lukas Westermann (ORCID: https://orcid.org/0000-0002-3525-3767)
- Johannes Wiegel (ORCID: https://orcid.org/0000-0002-4006-9307)
- Frederic Arnold (ORCID: https://orcid.org/0000-0001-6799-9152)
Institutions
- University of Freiburg (DE)
- University Medical Center Freiburg (DE)
- University Hospital of Zurich (CH)
Publication Details
- Journal
- American Journal of Nephrology
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1159/000543487
- Primary Topic
- Potassium and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00